XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Employee Stock and Benefit Plans (Tables)
 12 Months Ended
Oct. 03, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense Recognized in the Consolidated Financial Statements Stock-based compensation expense recognized in the consolidated financial statements (in millions):
Fiscal Year EndedOct 3, 2021Sep 27, 2020Sep 29, 2019
RSUs$316.9 $241.0 $288.0 
Options2.2 7.5 20.0 
Total stock-based compensation expense recognized in the consolidated statements of earnings$319.1 $248.5 $308.0 
Total related tax benefit$51.6 $47.8 $59.3 
Total capitalized stock-based compensation included in net property, plant and equipment on the consolidated balance sheets$3.7 $3.6 $3.4 
Stock Options Granted During the Period, Valuation Assumptions The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal 2021, 2020 and 2019:
Stock Options
Granted During the Period
Fiscal Year Ended202120202019
Expected term (in years)8.17.84.1
Expected stock price volatility26.3 %27.3 %21.6 %
Risk-free interest rate1.4 %1.2 %2.9 %
Expected dividend yield1.6 %2.9 %2.1 %
Weighted average grant price$110.46 $56.33 $67.33 
Estimated fair value per option granted$27.59 $11.30 $11.06 
Stock Option Transactions Stock option transactions for the year ended October 3, 2021 (in millions, except per share and contractual life amounts):
Shares
Subject to
Options		Weighted
Average
Exercise
Price
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Outstanding, September 27, 20209.2 $53.06 5.4$286 
Granted0.0 110.46 
Exercised(4.0)51.31 
Expired/forfeited0.0 56.69 
Outstanding, October 3, 20215.2 54.58 4.5303 
Exercisable, October 3, 20214.4 53.06 4.1261 
Vested and expected to vest, October 3, 20215.2 54.57 4.5302 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity RSU transactions for the year ended October 3, 2021 (in millions, except per share and contractual life amounts):
Number
of
Shares		Weighted
Average
Grant Date
Fair Value
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Nonvested, September 27, 20208.3 $74.23 1.1$699 
Granted4.1 96.05 
Vested(3.2)69.99 
Forfeited/canceled(1.5)87.72 
Nonvested, October 3, 20217.7 86.23 0.9869